{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:03:45Z","timestamp":1790834625979,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:00:00Z","timestamp":1541635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UNAH\u2019s Scientific Research Directorate","award":["S\/N"],"award-info":[{"award-number":["S\/N"]}]},{"DOI":"10.13039\/100011893","name":"Pan American Health Organization","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011893","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12936-018-2564-2","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T08:28:57Z","timestamp":1541665737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients"],"prefix":"10.1186","volume":"17","author":[{"given":"Sara","family":"Avalos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa E.","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engels","family":"Banegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lester","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzeth","family":"Galo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9756-4520","authenticated-orcid":false,"given":"Gustavo","family":"Fontecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,8]]},"reference":[{"key":"2564_CR1","unstructured":"WHO: World Malaria Report, 2017. Geneva: World Health Organization; 2017."},{"key":"2564_CR2","unstructured":"Ministry of Health of Honduras. Plan estrat\u00e9gico nacional para la eliminaci\u00f3n de la malaria en Honduras 2018\u20132023. Tegucigalpa, 2017."},{"key":"2564_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1475-2875-10-297","volume":"10","author":"NJ White","year":"2011","unstructured":"White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297.","journal-title":"Malar J."},{"key":"2564_CR4","doi-asserted-by":"publisher","first-page":"e0004582","DOI":"10.1371\/journal.pntd.0004582","volume":"10","author":"A Ross","year":"2016","unstructured":"Ross A, Koepfli C, Schoepflin S, Timinao L, Siba P, Smith T, et al. The incidence and differential seasonal patterns of Plasmodium vivax primary infections and relapses in a cohort of children in Papua New Guinea. PLoS Negl Trop Dis. 2016;10:e0004582.","journal-title":"PLoS Negl Trop Dis."},{"key":"2564_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1179\/2047773215Y.0000000016","volume":"109","author":"K Baird","year":"2015","unstructured":"Baird K. Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria. Pathog Glob Health. 2015;109:93\u2013106.","journal-title":"Pathog Glob Health."},{"key":"2564_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1475-2875-12-112","volume":"12","author":"L Seidlein von","year":"2013","unstructured":"von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J. 2013;12:112.","journal-title":"Malar J."},{"key":"2564_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1517\/14728214.2012.720252","volume":"17","author":"JK Baird","year":"2012","unstructured":"Baird JK. Reinventing primaquine for endemic malaria. Expert Opin Emerg Drugs. 2012;17:439\u201344.","journal-title":"Expert Opin Emerg Drugs."},{"key":"2564_CR8","doi-asserted-by":"publisher","first-page":"e1001339","DOI":"10.1371\/journal.pmed.1001339","volume":"9","author":"RE Howes","year":"2012","unstructured":"Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9:e1001339.","journal-title":"PLoS Med."},{"key":"2564_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/1475-2875-13-418","volume":"13","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014;13:418.","journal-title":"Malar J."},{"key":"2564_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12936-015-0823-z","volume":"14","author":"MA Zuniga","year":"2015","unstructured":"Zuniga MA, Mejia RE, Sanchez AL, Sosa-Ochoa WH, Fontecha GA. Glucose-6-phosphate dehydrogenase deficiency among malaria patients of Honduras: a descriptive study of archival blood samples. Malar J. 2015;14:308.","journal-title":"Malar J."},{"key":"2564_CR11","first-page":"171","volume":"44","author":"RJ Dern","year":"1954","unstructured":"Dern RJ, Beutler E, Alving AS. The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character. J Lab Clin Med. 1954;44:171\u20136.","journal-title":"J Lab Clin Med."},{"key":"2564_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/000992286700600416","volume":"6","author":"M Ziai","year":"1967","unstructured":"Ziai M, Amirhakimi GH, Reinhold JG, Tabatabee M, Gettner ME, Bowman JE. Malaria prophylaxis and treatment in G-6-PD deficiency. An observation on the toxicity of primaquine and chloroquine. Clin Pediatr (Phila). 1967;6:242\u20133.","journal-title":"Clin Pediatr (Phila)."},{"key":"2564_CR13","first-page":"653","volume":"74","author":"I Pannacciulli","year":"1969","unstructured":"Pannacciulli I, Salvidio E, Tizianello A, Parravidino G. Hemolytic effects of standard single dosages of primaquine and chloroquine on G-6-PD-deficient caucasians. J Lab Clin Med. 1969;74:653\u201361.","journal-title":"J Lab Clin Med"},{"key":"2564_CR14","first-page":"37","volume-title":"Norma Nacional de Malaria","author":"Secretar\u00eda Salud de","year":"2010","unstructured":"de Salud Secretar\u00eda, de Honduras Publica. Norma Nacional de Malaria. Tegucigalpa: Honduras; 2010. p. 37."},{"key":"2564_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/0923-2508(92)90107-Y","volume":"143","author":"X Lamballerie de","year":"1992","unstructured":"de Lamballerie X, Zandotti C, Vignoli C, Bollet C, de Micco P. A one-step microbial DNA extraction method using \u201cChelex 100\u201d suitable for gene amplification. Res Microbiol. 1992;143:785\u201390.","journal-title":"Res Microbiol"},{"key":"2564_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1475-2875-11-119","volume":"11","author":"GA Fontecha","year":"2012","unstructured":"Fontecha GA, Mendoza M, Banegas E, Poorak M, De Oliveira AM, Mancero T, et al. Comparison of molecular tests for the diagnosis of malaria in Honduras. Malar J. 2012;11:119.","journal-title":"Malar J."},{"key":"2564_CR17","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1073\/pnas.85.11.3951","volume":"85","author":"A Hirono","year":"1988","unstructured":"Hirono A, Beutler E. Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(\u2212). Proc Natl Acad Sci USA. 1988;85:3951\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2564_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4269\/ajtmh.2003.68.186","volume":"68","author":"LE Mombo","year":"2003","unstructured":"Mombo LE, Ntoumi F, Bisseye C, Ossari S, Lu CY, Nagel RL, et al. Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese school children. Am J Trop Med Hyg. 2003;68:186\u201390.","journal-title":"Am J Trop Med Hyg"},{"key":"2564_CR19","first-page":"601","volume":"67","author":"WHO","year":"1989","unstructured":"WHO. Glucose-6-phosphate dehydrogenase deficiency WHO Working Group. Bull World Health Organ. 1989;67:601\u201311.","journal-title":"Bull World Health Organ"},{"key":"2564_CR20","first-page":"476","volume":"24","author":"RK Saiki","year":"1992","unstructured":"Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia, 1985. Biotechnology. 1992;24:476\u201380.","journal-title":"Biotechnology."},{"key":"2564_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/03630269.2015.1012294","volume":"39","author":"BM Erazo","year":"2015","unstructured":"Erazo BM, Ramirez GA, Cerrato LE, Pinto LJ, Castro EJ, Yanez NJ, et al. Prevalence of Hb S (HHB: c.20A > T) in a Honduran population of African descent. Hemoglobin. 2015;39:134\u20137.","journal-title":"Hemoglobin."},{"key":"2564_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.trsl.2014.09.009","volume":"165","author":"JK Baird","year":"2015","unstructured":"Baird JK, Dewi M, Subekti D, Elyazar I, Satyagraha AW. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells. Transl Res. 2015;165:677\u201388.","journal-title":"Transl Res."},{"key":"2564_CR23","doi-asserted-by":"publisher","first-page":"854","DOI":"10.4269\/ajtmh.14-0194","volume":"91","author":"N LaRue","year":"2014","unstructured":"LaRue N, Kahn M, Murray M, Leader BT, Bansil P, McGray S, et al. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg. 2014;91:854\u201361.","journal-title":"Am J Trop Med Hyg"},{"key":"2564_CR24","doi-asserted-by":"publisher","first-page":"e0004457","DOI":"10.1371\/journal.pntd.0004457","volume":"10","author":"AW Satyagraha","year":"2016","unstructured":"Satyagraha AW, Sadhewa A, Elvira R, Elyazar I, Feriandika D, Antonjaya U, et al. Assessment of point-of-care diagnostics for G6PD deficiency in malaria endemic rural Eastern Indonesia. PLoS Negl Trop Dis. 2016;10:e0004457.","journal-title":"PLoS Negl Trop Dis."},{"key":"2564_CR25","doi-asserted-by":"publisher","first-page":"e116143","DOI":"10.1371\/journal.pone.0116143","volume":"9","author":"A Roca-Feltrer","year":"2014","unstructured":"Roca-Feltrer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A, et al. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia. PLoS One. 2014;9:e116143.","journal-title":"PLoS One"},{"key":"2564_CR26","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1590\/0037-8682-0134-2016","volume":"49","author":"MA Brito","year":"2016","unstructured":"Brito MA, Peixoto HM, Almeida AC, Oliveira MR, Romero GA, Moura-Neto JP, et al. Validation of the rapid test Carestart(\u2122) G6PD among malaria vivax-infected subjects in the Brazilian Amazon. Rev Soc Bras Med Trop. 2016;49:446\u201355.","journal-title":"Rev Soc Bras Med Trop"},{"key":"2564_CR27","doi-asserted-by":"publisher","first-page":"e28357","DOI":"10.1371\/journal.pone.0028357","volume":"6","author":"S Kim","year":"2011","unstructured":"Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, et al. Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS One. 2011;6:e28357.","journal-title":"PLoS One"},{"key":"2564_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1590\/0037-8682-0003-2017","volume":"50","author":"WM Monteiro","year":"2017","unstructured":"Monteiro WM, Brito MA, Lacerda MV. Accuracy of CareStart\u2122 G6PD rapid diagnostic test: variation in results from different commercial versions. Rev Soc Bras Med Trop. 2017;50:282\u20133.","journal-title":"Rev Soc Bras Med Trop."},{"key":"2564_CR29","unstructured":"CareStart\u2122 Glucose-6-phosphate dehydrogenase deficiency screening test. \n                    http:\/\/www.accessbio.net\/eng\/products\/products01_01.asp\n                    \n                  ."},{"key":"2564_CR30","unstructured":"WHO. Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale malaria. Policy brief (Global Malaria Programme ed.). Geneva: World Health Organization; 2016. p. 32."},{"key":"2564_CR31","volume-title":"Concentraciones de hemoglobina para diagnosticar la anemia y evaluar su gravedad","author":"Organizaci\u00f3n Mundial de la Salud","year":"2011","unstructured":"Organizaci\u00f3n Mundial de la Salud. Concentraciones de hemoglobina para diagnosticar la anemia y evaluar su gravedad. Suiza: Ginebra; 2011."},{"key":"2564_CR32","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00436-007-0742-1","volume":"101","author":"K Ghosh","year":"2007","unstructured":"Ghosh K, Ghosh K. Pathogenesis of anemia in malaria: a concise review. Parasitol Res. 2007;101:1463\u20139.","journal-title":"Parasitol Res"},{"key":"2564_CR33","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/S2214-109X(13)70001-9","volume":"1","author":"GA Stevens","year":"2013","unstructured":"Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995\u20132011: a systematic analysis of population-representative data. Lancet Glob Health. 2013;1:e16\u201325.","journal-title":"Lancet Glob Health."},{"key":"2564_CR34","doi-asserted-by":"publisher","first-page":"e0190272","DOI":"10.1371\/journal.pone.0190272","volume":"13","author":"GJH Bastiaens","year":"2018","unstructured":"Bastiaens GJH, Tiono AB, Okebe J, Pett HE, Coulibaly SA, Goncalves BP, et al. Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: two open-label, randomized, safety trials. PLoS One. 2018;13:e0190272.","journal-title":"PLoS One"},{"key":"2564_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/cid\/cix355","volume":"65","author":"RC Tine","year":"2017","unstructured":"Tine RC, Sylla K, Faye BT, Poirot E, Fall FB, Sow D, et al. Safety and efficacy of adding a single low dose of primaquine to the treatment of adult patients with Plasmodium falciparum malaria in Senegal, to reduce gametocyte carriage: a randomized controlled trial. Clin Infect Dis. 2017;65:535\u201343.","journal-title":"Clin Infect Dis"},{"key":"2564_CR36","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/infdis\/jiy014","volume":"217","author":"I Chen","year":"2018","unstructured":"Chen I, Diawara H, Mahamar A, Sanogo K, Keita S, Kone D, et al. Safety of single dose primaquine in G6PD-deficient and G6PD-normal males in Mali without malaria: an open-label, phase 1, dose-adjustment trial. J Infect Dis. 2018;217:1298\u2013308.","journal-title":"J Infect Dis"},{"key":"2564_CR37","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1128\/AAC.02889-14","volume":"58","author":"AC Eziefula","year":"2014","unstructured":"Eziefula AC, Pett H, Grignard L, Opus S, Kiggundu M, Kamya MR, et al. Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine. Antimicrob Agents Chemother. 2014;58:4971\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"2564_CR38","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1128\/AAC.01135-09","volume":"54","author":"SA Shekalaghe","year":"2010","unstructured":"Shekalaghe SA, ter Braak R, Daou M, Kavishe R, van den Bijllaardt W, van den Bosch S, et al. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother. 2010;54:1762\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"2564_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3347\/kjp.2006.44.3.221","volume":"44","author":"S Krudsood","year":"2006","unstructured":"Krudsood S, Wilairatana P, Tangpukdee N, Chalermrut K, Srivilairit S, Thanachartwet V, et al. Safety and tolerability of elubaquine (bulaquine, CDRI 80\/53) for treatment of Plasmodium vivax malaria in Thailand. Korean J Parasitol. 2006;44:221\u20138.","journal-title":"Korean J Parasitol"},{"key":"2564_CR40","doi-asserted-by":"publisher","first-page":"702","DOI":"10.4269\/ajtmh.16-0779","volume":"97","author":"R Rueangweerayut","year":"2017","unstructured":"Rueangweerayut R, Bancone G, Harrell EJ, Beelen AP, Kongpatanakul S, Mohrle JJ, et al. Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-normal volunteers. Am J Trop Med Hyg. 2017;97:702\u201311.","journal-title":"Am J Trop Med Hyg"},{"key":"2564_CR41","doi-asserted-by":"publisher","first-page":"e1002224","DOI":"10.1371\/journal.pmed.1002224","volume":"14","author":"CS Chu","year":"2017","unstructured":"Chu CS, Bancone G, Moore KA, Win HH, Thitipanawan N, Po C, et al. Haemolysis in G6PD heterozygous females treated with primaquine for Plasmodium vivax malaria: a nested cohort in a trial of radical curative regimens. PLoS Med. 2017;14:e1002224.","journal-title":"PLoS Med."},{"key":"2564_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1475-2875-13-70","volume":"13","author":"WM Monteiro","year":"2014","unstructured":"Monteiro WM, Franca GP, Melo GC, Queiroz AL, Brito M, Peixoto HM, et al. Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes. Malar J. 2014;13:70.","journal-title":"Malar J."},{"key":"2564_CR43","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12936-015-0647-x","volume":"14","author":"HM Peixoto","year":"2015","unstructured":"Peixoto HM, Brito MA, Romero GA, Monteiro WM, de Lacerda MV, de Oliveira MR. G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: a cost study. Malar J. 2015;14:126.","journal-title":"Malar J."},{"key":"2564_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12936-017-1925-6","volume":"16","author":"J Recht","year":"2017","unstructured":"Recht J, Siqueira AM, Monteiro WM, Herrera SM, Herrera S, Lacerda MVG. Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination. Malar J. 2017;16:273.","journal-title":"Malar J."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-018-2564-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-018-2564-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-018-2564-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T19:17:16Z","timestamp":1573154236000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-018-2564-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,8]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2564"],"URL":"https:\/\/doi.org\/10.1186\/s12936-018-2564-2","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,8]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"415"}}